Docosahexaenoic acid (DHA) is the most abundant n-3 polyunsaturated fatty acid in the human brain and works as an anticancer agent to induce cell cycle arrest and apoptosis in glioblastoma multiforme (GBM) cell lines. However， little is known about the connection between DHA and autophagy in GBM cells. We found that high-dose DHA caused cellular autophagy in cultured U251 and U118 GBM cell lines， but there was no effect with a low dose. Moreover， after treatment with a high dose of DHA at 12， 24， and 48?h， the protein expression of SQSTM1/p62 decreased in DHA-treated U251 cells at 12 and 24?h， but increased at 48?h， while in DHA-treated U118 cells， the protein expression increased at all time ... More
Docosahexaenoic acid (DHA) is the most abundant n-3 polyunsaturated fatty acid in the human brain and works as an anticancer agent to induce cell cycle arrest and apoptosis in glioblastoma multiforme (GBM) cell lines. However， little is known about the connection between DHA and autophagy in GBM cells. We found that high-dose DHA caused cellular autophagy in cultured U251 and U118 GBM cell lines， but there was no effect with a low dose. Moreover， after treatment with a high dose of DHA at 12， 24， and 48?h， the protein expression of SQSTM1/p62 decreased in DHA-treated U251 cells at 12 and 24?h， but increased at 48?h， while in DHA-treated U118 cells， the protein expression increased at all time points. Interestingly， the level of SQSTM1/p62 mRNA was elevated in both DHA-treated U251 and U118 cells at all time points， indicating that DHA activated SQSTM1/p62 transcription in both cell lines. Furthermore， downregulation of SQSTM1/p62 by siRNA attenuated DHA-induced cellular autophagy in both cell lines. This report confirms that high-dose DHA induces cellular autophagy in GBM cells， and demonstrates that SQSTM1/p62 acts as a regulator and participates in DHA-induced autophagy.
